Menu Search
Equities

MedPeer Inc

6095:TYO

MedPeer Inc

Actions
TechnologyTechnology
  • Price (JPY)587.00
  • Today's Change0.00 / 0.00%
  • Shares traded748.60k
  • 1 Year change-41.24%
  • Beta2.1021
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform0
Hold3
Sell0
Strong Sell0

Share price forecast in JPY

The 3 analysts offering 12 month price targets for MedPeer Inc have a median target of 650.00, with a high estimate of 800.00 and a low estimate of 600.00. The median estimate represents a 10.73% increase from the last price of 587.00.
High36.3%800.00
Med10.7%650.00
Low2.2%600.00

Dividends in JPY

In 2023, MedPeer Inc reported a dividend of 4.50 JPY. The 2 analysts covering the company expect dividends of 4.50 JPY for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)--
More ▼

Earnings history & estimates in JPY

MedPeer Inc reported annual 2023 earnings of 28.33 per share on Nov 13, 2023.
Average growth rate+18.98%
More ▼

Revenue history & estimates in JPY

MedPeer,Inc. had 3rd quarter 2024 revenues of 3.60m. This bettered the 3.49m estimate of the one analyst covering the company. This was 2.44% below the prior year's 3rd quarter results.
Average growth rate+0.62%
MedPeer,Inc. had revenues for the full year 2023 of 14.54m. This was 72.03% above the prior year's results.
Average growth rate+50.03%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.